Interview: siRNA-Loaded Stem Cell Exosomes, Inside NurExone Biologic’s Spinal Cord Injury Candidate
NurExone's SCI candidate showed 100% gait recovery in rat models, and they're gearing up for human trials hopefully in 2026. Enjoy the interview!
Exosomes/Extracellular Vesicles
New Study: Exosome Therapy from Umbilical Cord Stem Cells Shows Early Promise for Osteoarthritis
Researchers are testing whether exosomes from umbilical cord stem cells can safely reduce inflammation and support cartilage repair in osteoarthritis.
NurExone Granted U.S. Patent for Exosome Manufacturing Process, Enhancing Supply Chain Capabilities
NurExone secures U.S. patent protection for its exosome production method, supporting scale-up and clinical supply chain readiness.
Regenerative Spinal Cord Therapy: Interview with Nurexone Biologic’s CEO, Dr. Lior Shaltiel
Nurexone Biologic has developed an exosome therapy for nerve repair, we interviewed the CEO, Dr. Lior Shaltiel here. Enjoy!
NurExone’s Exosomes Outperform Commercial Standard in Regenerative Study
Independent analysis finds NurExone’s exosomes deliver enhanced regenerative signals, showing promise for nerve repair and tissue healing applications.
New Trial: Umbilical Cord Stem Cell-Derived Exosome Nasal Drops for Neurodegenerative Diseases
Researchers will test whether nasal drops containing stem cell-derived vesicles can safely benefit people with a range of neurodegenerative diseases.
New Trial: Mesenchymal Stem Cell Exosomes for Preventing and Treating Organ Failure After Aortic Dissection Surgery
Researchers in China are testing whether exosomes can help prevent or treat organ failure after aortic dissection surgery.
Stem Cell-Derived Extracellular Vesicles Show Promise for Respiratory Disease
Researchers are exploring whether stem cell-derived extracellular vesicles could offer safer, targeted therapies for respiratory diseases, but technical hurdles remain.
Exosomes Show Promise in Supporting Bone Fracture Healing and Regeneration
Researchers explored how exosomes could boost bone healing and pave the way for new regenerative therapies.
New Trial: iPSC-Derived Exosome Therapy for Moyamoya Disease
Researchers are testing whether exosomes from stem cells can enhance blood vessel repair for Moyamoya patients after surgery.
